The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen

National search will be conducted

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Wayne A. I. Frederick, a surgical oncologist and former president of Howard University, will step in as interim chief executive officer of the American Cancer Society, effective Nov. 2. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer

Patricio M. Polanco, a surgical oncologist specializing in hepato-pancreato-biliary malignancies and minimally invasive and robotic liver and pancreas surgery, has joined Atrium Health as division chief of surgical oncology, surgeon-in-chief for Atrium Health Levine Cancer in Charlotte, North Carolina and inaugural Richard L. White Jr. Endowed Professor of Surgery at Wake Forest University School of Medicine. 
Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
By Rodney Haring
ClinicalTrials & Tribulations

More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.
By AmirAli Talasaz
Byline
Paul Goldberg
Editor & Publisher
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account